methyltestosterone and Hot Flashes

methyltestosterone has been researched along with Hot Flashes in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (33.33)	18.2507
2000's	1 (33.33)	29.6817
2010's	1 (33.33)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Allgood, A; Derogatis, LR; Guo, CY; Liu, J; Nedoss, B; O'Mahony, M; Prokofieva, SV; Soper, H; Swanson, S; Zbella, E; Zipfel, L	1
Notelovitz, M	1
Bowen, A; Klaiber, E; Simon, J; Wiita, B; Yang, HM	1

Reviews

1 review(s) available for methyltestosterone and Hot Flashes

Article	Year
Hot flashes and androgens: a biological rationale for clinical practice. Mayo Clinic proceedings, 2004, Volume: 79, Issue:4 Suppl Topics: Algorithms; Androgens; Biological Availability; Blood-Brain Barrier; Body Temperature Regulation; Central Nervous System; Clinical Trials as Topic; Decision Trees; Estrogen Replacement Therapy; Evidence-Based Medicine; Female; Hormone Replacement Therapy; Hot Flashes; Humans; Menopause; Methyltestosterone; Patient Selection; Premenopause; Receptors, Androgen; Receptors, Estrogen; Testosterone	2004

Article

Year

Hot flashes and androgens: a biological rationale for clinical practice.

Mayo Clinic proceedings, 2004, Volume: 79, Issue:4 Suppl

Topics: Algorithms; Androgens; Biological Availability; Blood-Brain Barrier; Body Temperature Regulation; Central Nervous System; Clinical Trials as Topic; Decision Trees; Estrogen Replacement Therapy; Evidence-Based Medicine; Female; Hormone Replacement Therapy; Hot Flashes; Humans; Menopause; Methyltestosterone; Patient Selection; Premenopause; Receptors, Androgen; Receptors, Estrogen; Testosterone

2004

Trials

2 trial(s) available for methyltestosterone and Hot Flashes

Article	Year
Safety and efficacy of low-dose esterified estrogens and methyltestosterone, alone or combined, for the treatment of hot flashes in menopausal women: a randomized, double-blind, placebo-controlled study. Fertility and sterility, 2011, Volume: 95, Issue:1 Topics: Anabolic Agents; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Estrogen Replacement Therapy; Estrogens; Estrogens, Esterified (USP); Female; Hot Flashes; Humans; Menopause; Methyltestosterone; Placebos; Severity of Illness Index; Treatment Outcome	2011
Differential effects of estrogen-androgen and estrogen-only therapy on vasomotor symptoms, gonadotropin secretion, and endogenous androgen bioavailability in postmenopausal women. Menopause (New York, N.Y.), 1999,Summer, Volume: 6, Issue:2 Topics: Administration, Oral; Aged; Androgens; Biological Availability; Drug Administration Schedule; Drug Therapy, Combination; Estrogen Replacement Therapy; Estrogens; Female; Follicle Stimulating Hormone; Gonadotropins; Hot Flashes; Humans; Luteinizing Hormone; Methyltestosterone; Middle Aged; Multivariate Analysis; Pilot Projects; Postmenopause; Testosterone Congeners; Treatment Outcome; Vasomotor System	1999

Article

Year

Safety and efficacy of low-dose esterified estrogens and methyltestosterone, alone or combined, for the treatment of hot flashes in menopausal women: a randomized, double-blind, placebo-controlled study.

Fertility and sterility, 2011, Volume: 95, Issue:1

Topics: Anabolic Agents; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Estrogen Replacement Therapy; Estrogens; Estrogens, Esterified (USP); Female; Hot Flashes; Humans; Menopause; Methyltestosterone; Placebos; Severity of Illness Index; Treatment Outcome

2011

Differential effects of estrogen-androgen and estrogen-only therapy on vasomotor symptoms, gonadotropin secretion, and endogenous androgen bioavailability in postmenopausal women.

Menopause (New York, N.Y.), 1999,Summer, Volume: 6, Issue:2

Topics: Administration, Oral; Aged; Androgens; Biological Availability; Drug Administration Schedule; Drug Therapy, Combination; Estrogen Replacement Therapy; Estrogens; Female; Follicle Stimulating Hormone; Gonadotropins; Hot Flashes; Humans; Luteinizing Hormone; Methyltestosterone; Middle Aged; Multivariate Analysis; Pilot Projects; Postmenopause; Testosterone Congeners; Treatment Outcome; Vasomotor System

1999